A Study of LY3819253 (LY-CoV555) in Healthy Participants

NCT04537910 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3819253
DRUG: Placebo

Sponsor

Eli Lilly and Company